Industry Hopes FDA’s New Combo Products Chief Speeds Up Pending Rules
Executive Summary
FDA's Office of Combination Products says it is getting back on track with new leadership in place after months of flux. Industry meanwhile is pushing the office to accelerate the release of rules and guidelines to help companies navigate this relatively new area of regulation